STIP1 and esophageal squamous cell carcinoma: Other researchers proposed that simultaneous detection of antibodies against NY-ESO-1, STIP1 and MMP-7 had clinical value in the detection of early ESCC, but it was less effective in predicting the risk of ESCC [74].